Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Monocytes
Monocytes measure the number of circulating monocytes in the blood, reflecting immune system activity.
Reference ranges may vary slightly based on age and laboratory standards.
Monocytes, abbreviated as MONO, are a type of white blood cell that plays a crucial role in the body's immune response. They are part of the mononuclear phagocyte system and are primarily responsible for phagocytosis, the process of engulfing and digesting cellular debris and pathogens. Monocytes circulate in the bloodstream and migrate into tissues where they differentiate into macrophages and dendritic cells, contributing to the body's defense mechanisms. Researchers have found that monocytes are involved in various inflammatory processes and immune responses, making them a significant focus in the study of diseases such as gout, acute respiratory distress syndrome (ARDS), Alzheimer's disease, myeloproliferative neoplasms, and sepsis. Clinically, elevated monocyte levels can indicate chronic inflammation, infection, or hematological disorders, while low levels may suggest bone marrow suppression or autoimmune conditions. In the context of athletic performance, biohacking, or longevity, monocytes are less directly studied, but their role in inflammation and immune function makes them relevant for understanding recovery and resilience. Researchers observed that factors like time of day, fasting status, and recent physical activity can influence monocyte levels, which should be considered when interpreting test results.
Klinische Bedeutung
Elevated monocyte levels can indicate chronic inflammation, infection, or hematological disorders. Reduced monocyte levels may suggest bone marrow suppression or autoimmune conditions.
Progressively rising monocyte levels suggest increasing inflammation or infection; re-test in 4 weeks if outside optimal range.
Progressively falling monocyte levels may indicate resolving inflammation or potential bone marrow suppression.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplementation, especially if underlying health conditions exist.
Monocyte levels can fluctuate throughout the day; consistent timing is recommended for comparability.
Testing Frequency
Annually for healthy adults, more frequently if monitoring specific conditions.
Current research suggests that the reference ranges and optimal targets for monocyte subsets, particularly CD38high monocytes, remain unclear, as their roles in various conditions like sepsis and myelofibrosis are still being debated. Emerging research directions include the exploration of monocyte gene signatures in inflammatory diseases and their potential as biomarkers for disease progression. However, clinical questions regarding the long-term implications of monocyte activation states and their therapeutic targeting in diverse patient populations remain unanswered.
950
Total Citations
14
Human/RCT
4.4
Avg. Influence
2026
Latest
This review examined the role of monocyte subsets in tuberculosis infection. Researchers found alterations in the frequency of monocyte subsets during TB, suggesting their importance in the immune response and potential as biomarkers for disease progression.
Researchers reviewed the clinical significance of monocyte heterogeneity in human diseases. They emphasized the importance of identifying specific monocyte subpopulations as potential biomarkers for various health conditions, enhancing understanding of their roles in disease pathogenesis.
Researchers reviewed the role of calprotectin, produced by activated monocytes, in rheumatic diseases. They found that calprotectin levels correlate with disease activity and may serve as a sensitive biomarker for monitoring inflammation in autoimmune disorders.
Researchers investigated monocyte gene signatures in patients with acute respiratory distress syndrome (ARDS) using single-cell RNA sequencing. They found that monocytes from ARDS patients exhibited a proinflammatory gene profile and identified 29 upregulated genes that could serve as potential biomarkers for ARDS risk assessment.
This review compared the heterogeneity of bovine peripheral blood monocytes to their human counterparts. Researchers found functional differences between monocyte subsets in both species, suggesting that bovine intermediate monocytes may serve as biomarkers for inflammatory responses postpartum.
This review discussed the heterogeneity of monocytes in tumorigenesis and their role in cancer development. Researchers highlighted the potential of monocyte subsets as biomarkers for tumor progression and targets for immunotherapy.
This study examined the effects of monosodium urate (MSU) crystal deposition on immune responses in gout remission. Researchers found systemic inflammation characterized by activated inflammatory pathways and increased monocyte subtypes in patients with advanced gout. The findings suggest unique immune responses during gout remission that could inform future research.
This review highlights the role of monocyte and macrophage microRNAs as biomarkers for tuberculosis. Researchers discuss how these miRNAs can inform disease progression and therapeutic strategies, emphasizing their potential in host-directed therapy.
Researchers explored monocyte distribution width (MDW) as a biomarker for sepsis. They noted that MDW is calculated based on monocyte characteristics and may serve as an indicator of sepsis severity, independent of the causative pathogen.
This study explored the role of peripheral monocytes in the clearance of amyloid β in Alzheimer's disease. Researchers observed that Aβ-binding monocytes have high phagocytic potential and their levels correlate with disease progression, suggesting their potential as biomarkers for Alzheimer's diagnosis and monitoring.
Research publications about Monozyten over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer